Search All News
Leading physician and researcher, Lisa Kachnic, MD, will lead Columbia's department of radiation oncology.
Anil Rustgi, the new director of the Herbert Irving Comprehensive Cancer Center, talks about new ideas in cancer research, the best patient care, and the importance of physician-scientists.
A clinical trial at Columbia and other centers found that patients responded to a new “smart drug” for women with an aggressive form of breast cancer.
- May 4, 2018
An experimental immunotherapy improved one-year survival, as compared to historical rates, in a small trial of patients with advanced uveal melanoma.
- April 10, 2018
A new Science study from Columbia stem cell researchers has found that the liver is the surprising source of a growth factor that keeps bone marrow stem cells healthy.
- April 5, 2018
3-D organoids created from the bladder cancers of patients mimic the characteristics of each patient’s tumor and may be used in the future to identify the best treatment for each patient.
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
- February 28, 2018
Pathology’s new recruit, Kevin Gardner, talks about health disparities and the need for more diversity among research participants.
- February 21, 2018
Two new precision medicine tests that look beyond cancer genes to identify novel therapeutic targets are now available to both oncologists and cancer researchers.
- February 12, 2018
A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond best to chemotherapy.
- January 24, 2018
A mutation that leads to relapse in many leukemia patients also causes a weakness that could be exploited to kill the cancer cells, Columbia researchers have reported.
- January 18, 2018
Columbia researchers have identified two new breast cancer genes that also cause Lynch syndrome.
- January 11, 2018
A new study shows how stress accelerates pancreatic cancer development. Beta blockers, which block stress hormones, may increase survival for patients with the disease.